PDGFRB and neoplasm: In the latter example, expression of the PDGF receptor was primarily localized to stromal fibroblasts and pericytes, and inhibition of PDGFR signaling with Imatinib decreased pericyte coverage of tumor endothelial cells, concomitant with suppression of tumor vascularity and growth.